Henry O Gosebruch's Trading History
| ANIPANI Pharmaceuticals | Aug 27, 2026 | Director | Uninformative Buy | ― | $479.66K | |
| SLRNACELYRIN, INC. | May 23, 2025 | ― | Uninformative Sell | ― | $0.00 | |
| NMRANeumora Therapeutics, Inc. | Feb 16, 2024 | President & CEO, Director | Uninformative Buy | ― | $221.96K | |
| ABBVAbbVie | May 18, 2022 | EVP, Chief Strategy Officer | Uninformative Buy | 4.61M | $29.07M | |
| APTXAptinyx | Jan 14, 2020 | ― | Informative Buy | 75.00K | $12.00K |
You May Also Like
Henry O Gosebruch insider profile FAQ
What is the percentage of profitable transactions made by Henry O Gosebruch?
The percentage of profitable transactions made by Henry O Gosebruch is 63%.
What is the average return per transaction made by Henry O Gosebruch?
The average return per transaction made by Henry O Gosebruch is -10.00%.
What stocks does Henry O Gosebruch hold?
Henry O Gosebruch holds: ANIP, ABBV, APTX, SLRN, NMRA stocks.
What was Henry O Gosebruch's most profitable transaction?
Henry O Gosebruch’s most profitable transaction was an Informative Buy of ABBV stock on July 31, 2019. The return on the trade was 50.40%.
What is Henry O Gosebruch's role in ANI Pharmaceuticals?
Henry O Gosebruch's role in ANI Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.